REXAHN PHARMACEUTICALS INC
Q2 2015 13F Holders
CUSIP
761640101
Type
Equity
Class
COM
Num filings
35
Total reported value, excl. options
$5.36 M
Compare 2015 Q2 to
2018 Q3
2018 Q2
2018 Q1
2017 Q4
2017 Q3
2017 Q2
2017 Q1
2016 Q4
2016 Q3
2016 Q2
2016 Q1
2015 Q4
2015 Q3
2015 Q1
2014 Q4
2014 Q3
2014 Q2
2014 Q1
Manager
Report Date
Value ($000)
Shares
Option Type